Home Nav
Nextech Invest Logo

David M. Livingston

Alfred Scheidegger

David Livingston MD is chairman of the Nextech Invest Scientific Board and deputy director and professor of medicine and genetics, Dana-Farber Cancer Institute/Harvard Cancer Center, Harvard Medical School, USA, and a physician at Brigham and Women's Hospital, USA. He is the former chairman of the board of scientific advisors of the U.S. National Cancer Institute, a member of the Institute of Medicine of the National Academy of Sciences and its Institute of Medicine, USA, among other such bodies, and a consultant to numerous oncology companies.

 

Personalized Oncology 2019 conference

23.06. – 25.06.2019

Basel, Switzerland

  • 14.06.2019

    Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib...

  • 14.06.2019

    Blueprint Medicines Submits New Drug Application to...

  • 04.06.2019

    Arvinas and Bayer to Collaborate on Human PROTAC® Therapies...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close